IT1270831B - Composizioni farmaceutiche orali effervescenti contenenti estrone - Google Patents

Composizioni farmaceutiche orali effervescenti contenenti estrone

Info

Publication number
IT1270831B
IT1270831B ITMI932014A ITMI932014A IT1270831B IT 1270831 B IT1270831 B IT 1270831B IT MI932014 A ITMI932014 A IT MI932014A IT MI932014 A ITMI932014 A IT MI932014A IT 1270831 B IT1270831 B IT 1270831B
Authority
IT
Italy
Prior art keywords
pct
water
pharmaceutical compositions
compositions containing
soluble
Prior art date
Application number
ITMI932014A
Other languages
English (en)
Inventor
Romano Deghenghi
Original Assignee
Romano Deghenghi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romano Deghenghi filed Critical Romano Deghenghi
Publication of ITMI932014A0 publication Critical patent/ITMI932014A0/it
Priority to ITMI932014A priority Critical patent/IT1270831B/it
Priority to CA002171829A priority patent/CA2171829A1/en
Priority to DE69408579T priority patent/DE69408579T2/de
Priority to KR1019960701321A priority patent/KR100314338B1/ko
Priority to PCT/EP1994/002465 priority patent/WO1995007701A1/en
Priority to ES94925394T priority patent/ES2112555T3/es
Priority to AU75329/94A priority patent/AU7532994A/en
Priority to AT94925394T priority patent/ATE163265T1/de
Priority to JP7508930A priority patent/JPH09502709A/ja
Priority to US08/592,377 priority patent/US5720977A/en
Priority to EP94925394A priority patent/EP0719148B1/en
Priority to IL11047194A priority patent/IL110471A/en
Publication of ITMI932014A1 publication Critical patent/ITMI932014A1/it
Application granted granted Critical
Publication of IT1270831B publication Critical patent/IT1270831B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ITMI932014A 1993-09-17 1993-09-17 Composizioni farmaceutiche orali effervescenti contenenti estrone IT1270831B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI932014A IT1270831B (it) 1993-09-17 1993-09-17 Composizioni farmaceutiche orali effervescenti contenenti estrone
AU75329/94A AU7532994A (en) 1993-09-17 1994-07-26 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
JP7508930A JPH09502709A (ja) 1993-09-17 1994-07-26 エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物
KR1019960701321A KR100314338B1 (ko) 1993-09-17 1994-07-26 에스트론 유도체와 칼슘염을 포함하는 경구용 수용성약학적조성물
PCT/EP1994/002465 WO1995007701A1 (en) 1993-09-17 1994-07-26 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
ES94925394T ES2112555T3 (es) 1993-09-17 1994-07-26 Composiciones farmaceuticas orales solubles en agua que contienen derivado de estrona y sales de calcio.
CA002171829A CA2171829A1 (en) 1993-09-17 1994-07-26 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
AT94925394T ATE163265T1 (de) 1993-09-17 1994-07-26 Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
DE69408579T DE69408579T2 (de) 1993-09-17 1994-07-26 Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
US08/592,377 US5720977A (en) 1993-09-17 1994-07-26 Oral water soluble pharmaceutical compositions containing estrone compound and calcium salt
EP94925394A EP0719148B1 (en) 1993-09-17 1994-07-26 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
IL11047194A IL110471A (en) 1993-09-17 1994-07-27 Oral preparations are soluble in water containing estron history

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932014A IT1270831B (it) 1993-09-17 1993-09-17 Composizioni farmaceutiche orali effervescenti contenenti estrone

Publications (3)

Publication Number Publication Date
ITMI932014A0 ITMI932014A0 (it) 1993-09-17
ITMI932014A1 ITMI932014A1 (it) 1995-03-17
IT1270831B true IT1270831B (it) 1997-05-13

Family

ID=11366921

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932014A IT1270831B (it) 1993-09-17 1993-09-17 Composizioni farmaceutiche orali effervescenti contenenti estrone

Country Status (12)

Country Link
US (1) US5720977A (it)
EP (1) EP0719148B1 (it)
JP (1) JPH09502709A (it)
KR (1) KR100314338B1 (it)
AT (1) ATE163265T1 (it)
AU (1) AU7532994A (it)
CA (1) CA2171829A1 (it)
DE (1) DE69408579T2 (it)
ES (1) ES2112555T3 (it)
IL (1) IL110471A (it)
IT (1) IT1270831B (it)
WO (1) WO1995007701A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6726922B1 (en) 1999-06-28 2004-04-27 Minu, L.L.C. Process and composition for temporarily suppressing pain
CA2384104A1 (en) * 1999-09-08 2001-03-15 Melanie K. Spriggs Use of semaphorin for modulation of cellular efflux
DK1361881T3 (da) * 2000-12-14 2006-02-20 Ortho Mcneil Pharm Inc Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
US20030068356A1 (en) 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
US8217024B2 (en) 2005-12-27 2012-07-10 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms

Also Published As

Publication number Publication date
JPH09502709A (ja) 1997-03-18
ES2112555T3 (es) 1998-04-01
EP0719148A1 (en) 1996-07-03
KR100314338B1 (ko) 2002-02-28
ATE163265T1 (de) 1998-03-15
IL110471A (en) 1998-10-30
IL110471A0 (en) 1994-10-21
US5720977A (en) 1998-02-24
ITMI932014A0 (it) 1993-09-17
ITMI932014A1 (it) 1995-03-17
DE69408579T2 (de) 1998-06-18
AU7532994A (en) 1995-04-03
CA2171829A1 (en) 1995-03-23
WO1995007701A1 (en) 1995-03-23
EP0719148B1 (en) 1998-02-18
DE69408579D1 (de) 1998-03-26

Similar Documents

Publication Publication Date Title
ATE302588T1 (de) Dentales produkt gegen zahnstein und betreffende methode
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
IL115357A (en) Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
AU5453894A (en) Antibacterial mouthwash
IL110121A0 (en) Stable finished formulations for crop protection and their preparation
AU1537095A (en) Therapeutic agents containing thyroid hormones
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
BG104841A (en) Fizzy formulations
NZ515781A (en) Compositions and methods comprising morphine gluconate
GB0031312D0 (en) Macrolides
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
ATE311844T1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
DK0680326T3 (da) Farmaceutisk formulering af nikotinafhængighed.
BRPI0410116A (pt) tablete de cuidado oral
DK0673245T3 (da) Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
MY109531A (en) Effervescent antacid
BG104679A (en) The use of fumaric acid derivatives in transplant medicine
ITMI932014A1 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
HU9503214D0 (en) Pour-on formulations containing polymeric material, glycols and glycerides
GB9424766D0 (en) Pharmaceutical composition
IL78061A (en) Pharmaceutical compositions based on simethicone and guar gum for protection of the oesogastroduodenal mucous membrane
HRP20030002A2 (en) STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
AU3455093A (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
IL109975A (en) N-[[1-[4- (4-fluorophenoxy)butyl]-4- piperidinyl¾-n-methylamino]-2-benzothiazolols their preparation and pharmaceutical compositions containing them
CA2081408A1 (en) Composition for the cleaning of teeth and the prophylaxis of caries

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970926